Literature DB >> 3771715

Determination of metoprolol in plasma and urine using high-resolution gas chromatography and electron-capture detection.

M Ervik, K Kylberg-Hanssen, L Johansson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3771715     DOI： 10.1016/s0378-4347(00)83577-x

Source DB:  PubMed          Journal:  J Chromatogr


× No keyword cloud information.
  11 in total

1.  Subjective symptoms and pharmacokinetics/dynamics of metoprolol CR in elderly subjects--a comparison with atenolol.

Authors:  E S Dimenäs; C G Dahlöf; B Heibel; R G Moore; B K Olofsson; G E Westergren; P W Lücker
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

2.  Pharmacokinetic and pharmacodynamic properties of a new controlled-release formulation of metoprolol: a comparison with conventional tablets.

Authors:  A Sandberg; I Blomqvist; U E Jonsson; P Lundborg
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

3.  Pharmacokinetics and pharmacodynamics of controlled-release metoprolol: a comparison with atenolol.

Authors:  I Blomqvist; G Westergren; A Sandberg; U E Jonsson; P Lundborg
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

4.  Pharmacokinetic and pharmacodynamic comparison of a new controlled-release formulation of metoprolol with a traditional slow-release formulation.

Authors:  B Oosterhuis; J H Jonkman; F A Kerkhof
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

5.  Local beta-adrenergic blockade does not reduce infarct size after coronary occlusion and reperfusion: a study of coronary venous retroinfusion of metoprolol.

Authors:  S Kobayashi; H Tadokoro; L Rydén; P O Sjöquist; R V Haendchen; E Corday
Journal:  Cardiovasc Drugs Ther       Date:  1993-02       Impact factor: 3.727

6.  Steady-state bioavailability and day-to-day variability of a multiple-unit (CR/ZOK) and a single-unit (OROS) delivery system of metoprolol after once-daily dosing.

Authors:  A Sandberg; B Abrahamsson; A Svenheden; B Olofsson; R Bergstrand
Journal:  Pharm Res       Date:  1993-01       Impact factor: 4.200

7.  Inhibition of platelet accumulation by beta 1-adrenoceptor blockade in the thoracic aorta of rabbits subjected to experimental sympathetic activation.

Authors:  K Pettersson; H Björk
Journal:  Cardiovasc Drugs Ther       Date:  1992-10       Impact factor: 3.727

8.  Controlled-release metoprolol compared with atenolol in asthmatic patients: interaction with terbutaline.

Authors:  C G Löfdahl; C Dahlöf; G Westergren; B Olofsson; N Svedmyr
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

9.  Receptor binding assays in analysing the bioavailability and pharmacodynamic bioequivalence of active drug moieties. A study of metoprolol.

Authors:  T Kaila; L Roivas; P J Neuvonen
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

10.  Absence of beneficial effect of intravenous metoprolol given during angioplasty in patients with single-vessel coronary artery disease.

Authors:  J W de Jong; J J Bonnier; T Huizer; R Ciampricotti; J R Roelandt
Journal:  Cardiovasc Drugs Ther       Date:  1993-08       Impact factor: 3.727
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.